Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Heitz, F.; Harter, P.; Kimmig, R. et al.
The prognostic value of tumor residuals (TR) indicated by surgeon (SA), by radiology (RA), or an integrated approach (IA) by surgeons' assessment and pre-chemotherapy CT-scan in patients with advanced ovarian cancer: An exploratory analysis of the AGO led Intergroup trial AGO-OVAR 12ONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 12-12
Witzel, I.; Laakmann, E.; Weide, R. et al.
Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network RegistryEUROPEAN JOURNAL OF CANCER. Bd. 102. 2018 S. 1-9
de Boniface, Jana; Schmidt, Marcus; Engel, Jutta et al.
What Is the Best Management of cN0pN1(sn) Breast Cancer Patients?BREAST CARE. Bd. 13. H. 5. 2018 S. 331-336
Muenster, Eva; Letzel, Stephan; Passet-Wittig, Jasmin et al.
Who is the gate keeper for treatment in a fertility clinic in Germany? -baseline results of a prospective cohort study (PinK study)-BMC PREGNANCY AND CHILDBIRTH. Bd. 18. 2018
Merzenich, Hiltrud; Bartkowiak, Detlef; Schmidberger, Heinz et al.
3D conformal radiotherapy is not associated with the long-term cardiac mortality in breast cancer patients: a retrospective cohort study in Germany (PASSOS-Heart Study)BREAST CANCER RESEARCH AND TREATMENT. Bd. 161. H. 1. 2017 S. 143-152
Schwab, R.; Battista, M. J. B.; Kuenzel, K. et al.
A CASE OF UTERINE RELAPSE IN A YOUNG WOMAN WITH A HISTORY OF ALL (ACUTE LYMPHOBLASTIC LEUKEMIA)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Bd. 27. 2017 S. 995-995
Thomssen, Christoph; Decker, Thomas; Fehm, Tanja et al.
A PHASE II STUDY OF METRONOMIC DAILY ORAL VINORELBINE AS FIRST-LINE CHEMOTHERAPY IN ADVANCED/METASTATIC HORMONE RECEPTOR POSITIVE (HR plus )/HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 NEGATIVE (HER2-) BREAST CANCER RESISTANT TO ENDOCRINE THERAPY: VINOMETROBREAST. Bd. 36. 2017 S. S51-S51
Harbeck, Nadia; Saupe, Steffen; Jaeger, Elke et al.
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN studyBREAST CANCER RESEARCH AND TREATMENT. Bd. 161. H. 1. 2017 S. 63-72
Loibl, Sibylle; Barinoff, Jana; Seiler, Sabine et al.
A randomized, open-label, multicentre, phase IV study evaluating palbociclib plus endocrine treatment versus a chemotherapy based treatment strategy in patients with hormone receptor positive/HER2-negative metastatic breast cancer in a real world settingJOURNAL OF CLINICAL ONCOLOGY. Bd. 35. 2017
Heimes, A. S.; Schmidt, M.; Jaekel, J. et al.
A RETROSPECTIVE ANALYSIS OF IMMUNOHISTOCHEMICAL DETERMINED IRF4 (INTERFERON REGULATING FACTOR 4) EXPRESSION IN A CONSECUTIVE COHORT OF 114 OVARIAN CANCER PATIENTSINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Bd. 27. 2017 S. 1520-1520